Skip to main content
. 2013 Jun 27;24(8):1323–1329. doi: 10.1681/ASN.2012080771

Table 1.

PLA2R1 and HLA-DQA1 polymorphisms in patients with IMN and healthy controls in a Chinese population

Variant Gene Position Allele Controls (n=1020) IMN Patients (n=1112) OR (95% CI)a P Value Adjusted P Valueb
rs35771982 PLA2R1 Exon 5 C 615 (30.1) 344 (15.5) 2.36 1.90×10−30 1.14×10−29
G 1425 (69.9) 1880 (74.5) (2.03 to 2.74)
rs3749117 PLA2R1 Exon 5 C 611 (30.0) 346 (15.6) 2.32 2.23×10−29 1.34×10−28
T 1429 (70.0) 1878 (84.4) (2.00 to 2.69)
rs4664308 PLA2R1 Intron A 1427 (70.0) 1880 (84.5) 2.35 4.17×10−30 2.50×10−29
G 613 (30.0) 344 (15.5) (2.02 to 2.73)
rs2187668 HLA-DQA1 Intron A 110 (5.4) 270 (12.1) 2.42 1.11×10−14 6.66×10−14
G 1930 (94.6) 1954 (87.8) (1.93 to 3.05)
rs11244 HLA-DOB 3′ untranslated region variant C 1506 (73.9) 1641 (73.8) 1.001 0.98
T 534 (26.1) 583 (26.2) (0.87 to 1.15)
rs2301271 HLA-DQB2 Intron C 1719 (84.3) 1851 (83.2) 1.08 0.36
T 321(15.7) 373 (16.8) (0.92 to 1.27)
a

OR modeled for minor allele.

b

Bonferroni correction was used when the adjusted P value was reported.